ACADEMIC MEDICAL RESEARCH INSTITUTE
Currently Recruiting
STUDY: IgA Nephropathy,
This study will evaluate the efficacy of Investigational Medication compared with placebo to reduce proteinuria in adult participants with IgAN
Key Inclusion Criteria:
1. Participant must be ≥ 18 years of age at the start of the study
2. Established diagnosis of primary IgAN based on kidney biopsy.
3. Proteinuria ≥ 1 g/g measured by urine protein to creatinine ratio (UPCR)
Why join a clinical trial?
- Access to highly experienced physicians and their trained research teams, no cost to participants.
- Clinical trials offer more care options for your condition, with access to new medicines at no cost.
- Participation is voluntary, and during informed consent process, you will learn all details about the study
- Receive compensation, and free transportation if you qualify.
- Help move science forward and improve improve human health, wellbeing, and quality of life
STUDY: Hypertension Not Adequately Controlled
The clinical trial is to evaluate the add-on effect of New Medication on Blood Pressure control
Key Inclusion Criteria
1. Male or female age 40 years or older at the time of initial informed consent.
2. History or high risk of Cardiovascular disease.
3.Treated hypertension on stable therapy with 2 to 4 antihypertensive medications.
4.Seated automated mean office Systolic Blood Pressure at ≥140 mmHg
Why join a clinical trial?
- Access to highly experienced physicians and their trained research teams, no cost to participants.
- Clinical trials offer more care options for your condition, with access to new medicines at no cost.
- Participation is voluntary, and during informed consent process, you will learn all details about the study
- Receive compensation, and free transportation if you qualify.
- Help move science forward and improve improve human health, wellbeing, and quality of life
STUDY: Membranous Nephropathy
A Phase 3 Study on Efficacy of Investigational Medication in Adults with Primary Membranous Nephropathy (PMN)
Key Inclusion Criteria:
1. ≥ 18 years old
2. Biopsy-proven membranous glomerulonephritis or a diagnosis of MN in patients with Nephrotic Syndrome and a positive anti PLA2R antibody test.
3. Patients classified to be at a High Risk for progressive loss of kidney function.
4. eGFR by Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) formula ≥40 mL/min/1.73 m2
Why participate in a clinical trial?
- Access to highly experienced physicians and their trained research teams, no cost to participants.
- Clinical trials offer more care options for your condition, with access to new medicines at no cost.
- Participation is voluntary, and during informed consent process, you will learn all details about the study
- Receive compensation, and free transportation if you qualify.
- Help move science forward and improve improve human health, wellbeing, and quality of life
STUDY: Glomerular Kidney Disease with Proteinuria, including:
- Diabetic Kidney Disease Type 1 or Type 2
- Focal and Segmental Glomerulosclerosis (FSGS)
- Membranous Nephropathy.
- IgA Nephropathy
Main Inclusion Criteria
1. Adults of any race, age 18 to 65 years.
2. Diagnosis of one of the following glomerular kidney diseases with Proteinuria:
-- Type 1 or Type 2 diabetes mellitus with chronic kidney disease (CKD)
- Focal and Segmental Glomerulosclerosis (FSGS)
- Membranous Nephropathy.
- IgA Nephropathy
3. Estimated glomerular filtration rate (eGFR), calculated by the Chronic Kidney Disease-
Epidemiology Collaboration (CKD-EPI) equation method, ≥ 30 mL/min/1.73 m2 at Screening.
Why participate in a clinical trial?
- Access to highly experienced physicians and their trained research teams, no cost to participants.
- Clinical trials offer more care options for your condition, with access to new medicines at no cost.
- Participation is voluntary, and during informed consent process, you will learn all details about the study
- Receive compensation, and free transportation if you qualify.
- Help move science forward and improve improve human health, wellbeing, and quality of life
5830 E. Whittier Blvd.
Los Angeles, CA 90022
P: 323-725-7149
F: 323-869-9245
Google Translator
If you qualify and complete all required study visits, and procedures, you would be entitled to a compensation of up to $1600.00. The full details of the payment amount and schedule will be discussed with you at your first visit and will be outlined in the informed consent document.